News

BioTech Bootcamp launched

Published

on

A new international training programme for future biotech entrepreneurs who want to develop and commercialise their ventures has been launched. 

BioTech Bootcamp is an eight-week digital training program, where up to 12 teams from Sweden, Denmark and Germany will have the opportunity to develop their business ideas. 

Through expert lectures, individual coaching and mentorship, the participants receive training in entrepreneurship and a unique insight into the biotech industry, to prepare them for meeting investors, pharmaceutical companies and other industry players already at an early stage.

BioTech Bootcamp has been created by German-based BioM, one of Europe’s leading biotechnology clusters, alongside Swedish life science business incubator SmiLe. It is sponsored by Merck, a global leader in pharmaceuticals and life science technology.  

“There is a lot of good research in biotechnology at our universities, but we need to be better at utilising and commercialising it. We are therefore extremely proud of the tailor-made Bootcamp program for future biotech entrepreneurs we have developed together with Bio,” says Ebba Fåhraeus, VD of SmiLe.

Bootcamp creates a platform for entrepreneurs to verify their development plans and product ideas, exchange knowledge and network with peers in an international environment. The program also provides valuable contacts to the pharmaceutical industry as well as the major life science clusters in Sweden, Denmark and Germany.

“We are delighted to launch the BioTech Bootcamp together with SmiLe. Based on our complementary expertise, we have developed a unique curriculum. In addition to providing access to the networks of two European biotech hotspots, the program will boost the chances of the participating teams to build successful start-ups,” says Dr Petra Burgstaller, head of InQlab, BioM Biotech Cluster Development GmbH.

BioTech Bootcamp starts on September 6, 2021 and ends with the BioEntrepreneurship Summit week run by BioM, where the participants have the opportunity to meet other European entrepreneurs, representatives of the pharmaceutical industry and investors. In addition to this, Merck will award two winners with a trip to their M Lab Collaboration Center in Molsheim, France to meet experts and build networks.

The centre is Merck’s first in Europe, providing biopharmaceutical manufacturers with an opportunity to collaborate closely with Merck scientists and engineers to solve their toughest challenges and accelerate development of new therapies.

After completing the program there is a possibility for the participants to be accepted into more extensive programs at SmiLe to realise their business ideas.

Click to comment

Trending stories

Exit mobile version